Sensodyne Maker Haleon Cuts Revenue Growth Forecast on Weak Flu Season, China Disruption

Sensodyne maker Haleon cuts revenue growth forecast on weak flu season ...

Haleon shares crater as soft flu demand hits takings

Shares in Haleon slumped after soft demand for cough, cold and flu medicines forced the consumer healthcare giant to cut its revenue target. The FTSE 100 firm lost more than 11 per cent in early trading, to 333p. Haleon had been expecting revenue growth of between three and five per cent but on Thursday trimmed [...]

Haleon’s guidance cut disappoints, but long-term appeal remains

Haleon Shares Dive After Advil Maker Cuts Guidance

Performance was held back by weaker sales in cough, cold and flu products, particularly with lower orders in North America.

Haleon's growth slows as weak cold and flu season bites

Haleon reported slower-than-expected third-quarter revenue growth as a weak cold and flu season and a regulatory issue in China held back the consumer health company. The maker of Sensodyne toothpaste and Centrum vitamins said organic revenue grew 2.6% in the quarter, below expectations, with most growth coming from price rather than volume. The battle between […]